Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

Affimed N.V.. (3/15/18). "Press Release: Affimed to Present Data on AFM24 at AACR Annual Meeting 2018". Heidelberg.

Organisations Organisation Affimed N.V. (Nasdaq: AFMD)
  Group Affimed (Group)
  Organisation 2 American Association for Cancer Research (AACR)
Products Product AFM24 (EGFRwt/CD16A TandAb, Affimed)
  Product 2 AACR Annual Meeting 2018 Chicago
Person Person Alexandru, Anca (Affimed 201602– Head of Communications before MacDougall 201501 European Office)
     


Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today the presentation of preclinical data for the Company’s AFM24 program at the AACR Annual Meeting 2018 in Chicago, IL.


Poster Presentation

Abstract: Pharmacokinetics and in vitro/in vivo characterization of high-affinity bispecific EGFR/CD16A NK cell engagers for the treatment of EGFR-expressing tumors (#2786)

Session: PO.IM02.11 - Therapeutic Antibodies, Including Engineered Antibodies 2

Date and Time: Monday, April 16, 2018 1:00 PM - 5:00 PM (CT)

Location: McCormick Place South, Exhibit Hall A, Poster Section 34/Board 19, Chicago, IL

Full abstract of the presentation can be accessed on the AACR website at www.aacr.org


About Affimed N.V.

Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK and T cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information, please visit www.affimed.com.


Contact:

Anca Alexandru, Head of Communications, EU IR Phone: +49 6221 64793341 E-Mail: a.alexandru@affimed.com, IR@affimed.com

   
Record changed: 2018-03-31

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Affimed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top